Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nesrine Hemdani

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Medical Case Reports|January 18, 2024
Eosinophilic enterocolitis: a case reportHend Smaoui, Abdelwaheb Nakhli, Nesrine Hemdani, et al.
Case Reports in Oncology|July 31, 2025
Spontaneous Necrosis of Hepatocellular Carcinoma in Viral B Cirrhosis: A Case ReportYasmine Hidous, Abdelwaheb Nakhli, Emna Mrabet, et al.
La Tunisie Medicale|February 19, 2026
Conventional regimen versus split-dose regimen in bowel preparation: Results of a randomized controlled trialSoumaya Nsibi, Abdelwahab Nakhli, Cyrine Ben Mehrez, et al.
BMC Infectious Diseases|December 25, 2025
Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD studyMonia Fekih, Taieb Jomni, Myriam Ayari, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Medical Case Reports|January 18, 2024
Eosinophilic enterocolitis: a case reportHend Smaoui, Abdelwaheb Nakhli, Nesrine Hemdani, et al.
Case Reports in Oncology|July 31, 2025
Spontaneous Necrosis of Hepatocellular Carcinoma in Viral B Cirrhosis: A Case ReportYasmine Hidous, Abdelwaheb Nakhli, Emna Mrabet, et al.
La Tunisie Medicale|February 19, 2026
Conventional regimen versus split-dose regimen in bowel preparation: Results of a randomized controlled trialSoumaya Nsibi, Abdelwahab Nakhli, Cyrine Ben Mehrez, et al.
BMC Infectious Diseases|December 25, 2025
Helicobacter pylori eradication rate following first line non-bismuth quadruple therapy regimen in Tunisian patients: the HPERAD studyMonia Fekih, Taieb Jomni, Myriam Ayari, et al.
Pageof 1